Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study

doi:10.4254/wjh.v17.i5.104041

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (351)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

HTML

278

Figures (1-5)

Tables (1-6)

Sum=325

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=15

May 27, 2025 (publication date) through May 30, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. May 27, 2025; 17(5): 104041
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.104041

Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study

Tuong-Anh Mai-Phan, Trong-Kha Nguyen, Tri-Nhan Pham, Minh-Quang Tran, Kim-Long Le

Tuong-Anh Mai-Phan, Trong-Kha Nguyen, Tri-Nhan Pham, Minh-Quang Tran, Kim-Long Le, Department of Hepato-Pancreato-Biliary, Nhan dan Gia Dinh Hospital, Ho Chi Minh City 07000, Viet Nam

Tuong-Anh Mai-Phan, Medicine Faculty, Nguyen Tat Thanh University, Ho Chi Minh City 700000, Vietnam

Tri-Nhan Pham, Minh-Quang Tran, Kim-Long Le, Department of Surgery, Pham Ngoc Thach University of Medicine, Ho Chi Minh City 07000, Viet Nam

Author contributions: Mai-Phan TA and Nguyen TK designed the study; Mai-Phan TA supervised the generation of the study; Nguyen TK was responsible for developing the methodology; Le KL and Nguyen TK participated in the formal and statistical data analysis, and overall investigation; Nguyen TK, Le KL, Tran MQ, and Pham TN wrote the original draft; Pham TN and Tran MQ were responsible for the data visualization; Mai-Phan TA, Le KL, Nguyen TK, Tran MQ, and Pham TN participated in the review and editing of the manuscript; Le KL and Mai-Phan TA reviewed and edited the successive versions of the manuscript; All authors reviewed and approved the final version of the manuscript.

Institutional review board statement: The study was approved by the Institutional Review Board of Nhan dan Gia Dinh Hospital (Approval No. 127/NDGD-HDDD).

Informed consent statement: As this was a retrospective cohort study utilizing data from existing medical records, the requirement for obtaining signed informed consent forms was waived by the ethics committee in accordance with applicable ethical guidelines, including the Declaration of Helsinki. Patient confidentiality and data protection were ensured throughout the study.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.

Data sharing statement: The data supporting the findings of this study are available from the corresponding author, Kim-Long Le, upon reasonable request. Access to the data will be granted provided that the request complies with ethical guidelines and data protection regulations, including maintaining patient confidentiality as per the Declaration of Helsinki and institutional policies.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Kim-Long Le, MD, Lecturer, Department of Hepato-Pancreato-Biliary, Nhan dan Gia Dinh Hospital, 1 No Trang Long, Ward 7, Binh Thanh District, Ho Chi Minh City 07000, Viet Nam. longlk@pnt.edu.vn

Received: December 9, 2024
Revised: February 19, 2025
Accepted: April 17, 2025
Published online: May 27, 2025
Processing time: 170 Days and 13 Hours

Core Tip

Core Tip: The Hong Kong Liver Cancer (HKLC) staging system demonstrated superior prognostic accuracy in Vietnamese patients with hepatocellular carcinoma (HCC), outperforming other established models such as, cancer of the liver Italian program, and Italian liver cancer. These findings highlight the HKLC system’s clinical utility, particularly in stratifying risk and guiding treatment decisions for Asian populations with diverse viral etiologies. Notably, patients with non-viral HCC exhibited poorer outcomes, emphasizing the need for improved screening strategies in this subgroup to enhance early detection and survival.